{"id":"W3110384593","doi":"10.1016/j.annonc.2020.10.454","title":"190P Outcomes from the Asian region of the phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for patients (pts) with resected pancreatic cancer (PC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Ipsen; Bristol-Myers Squibb","keywords":"Medicine; Gemcitabine; Internal medicine; Neutropenia; Gastroenterology; Clinical endpoint; Pancreatic cancer; Population; Adverse effect; Surgery; Cancer; Randomized controlled trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001810093,0.0009501876,0.00144644,0.0003268643,0.0003915458,0.001232552,0.0006346378,0.000975113,0.004078651],"category_scores_gemma":[0.001649357,0.0002829714,0.003971055,0.0007262079,0.0005303935,0.0009998787,0.000719218,0.002525445,0.0006708755],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009863225,"about_ca_system_score_gemma":0.001380259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003010168,"about_ca_topic_score_gemma":0.006276278,"domain_scores_codex":[0.9993811,0.0002970526,0.0000422826,0.00009283362,0.00007523634,0.0001114811],"domain_scores_gemma":[0.998811,0.0002801341,0.0002976934,0.00009570987,0.0001180828,0.0003973416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.909136,0.002336796,0.02930612,0.0008664563,0.007993963,0.0001933193,0.0001038573,0.002663245,0.002607483,0.0003567844,0.01158111,0.03285494],"study_design_scores_gemma":[0.4622615,0.1815779,0.3056585,0.0004446811,0.02282502,0.0009426621,0.0005429771,0.004151344,0.00311116,0.002131625,0.01618436,0.0001682944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9668793,0.006403175,0.0004599329,0.002021265,0.0005851606,0.0005598541,0.01654476,0.00006062161,0.006485998],"genre_scores_gemma":[0.9735184,0.002494247,0.0004593698,0.001989322,0.0005190077,0.0006165648,0.01675808,0.00003818206,0.003606842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004078651,"threshold_uncertainty_score":0.01364446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1297472313214951,"score_gpt":0.4162685513837984,"score_spread":0.2865213200623033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}